Interpharm Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPAH research report →
Companywww.interpharmusa.com
Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. The company supplies its medicines to major retailers, wholesalers, managed care organizations, and national distributors.
- CEO
- Raj Sutaria
- IPO
- 2000
- Employees
- 670
- HQ
- Hauppauge, US
Price Chart
Valuation
- Market Cap
- $270.77K
- P/E
- -0.02
- P/S
- 0.00
- P/B
- 0.02
- EV/EBITDA
- -3.27
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 28.66%
- Op Margin
- -14.21%
- Net Margin
- -18.60%
- ROE
- -82.09%
- ROIC
- -19.23%
Growth & Income
- Revenue
- $75.59M · 19.31%
- Net Income
- $-14,058,000 · -270.92%
- EPS
- $-0.26 · -73.33%
- Op Income
- $-10,738,000
- FCF YoY
- -266.51%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -120.16
- Avg Volume
- 1.24K
Get TickerSpark's AI analysis on IPAH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IPAH Coverage
We haven't published any research on IPAH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IPAH Report →